In a prospective study by Gross et al., higher sICAM1 levels were associated significantly and in a graded fashion with common CIMT in participants with advanced plaque.18 The study indicated an early (mean age 40 years) involvement of sCAM1 in the development of atherosclerosis, independent of traditional cardiovascular risk factors and CRP levels. Here, CRP is linked to atherosclerosis.